References
- Ginsberg J. Diagnosis and Management of Grave’s Disease CMAJ. 2003;168(5):575–585.
- Yamada M, Li AW, Wall JR. Thyroid Associated ophthal- mopathy: Clinical Features, Pathogenesis, and Management Critical Reviews in Clinical Laboratory Sciences. 2000; 37(6):523–549.
- Wiersinga W, Bartalena L. Epidemiology and Prevention of Grave’s Ophthalmopathy Thyroid. 2002;12(10):855–860.
- Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic mani- festations. J Am Acad Dermatol. 2003;48:641–659.
- Tomer Y, Concepcion E, Greenberg D. A C/T single- nucleotide polymorphism in the region of the CD40 gene is associated with Grave’s disease. Thyroid. 2002; 12(12):1129–1135.
- Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Gorbes GS, Kline RW, Buettner H, Robertson DM, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. A prospective, randomized, double-blind, placebo-controlled study of orbital radiother- apy for Grave’s ophthalmopathy. Ophthalmology. 2001; 108(9):1523–1534.
- Feldon S. Radiation therapy for Grave’s ophthalmopathy: Trick or Treat? Ophthalmology. 2001;108(9):1521–1522.
- Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Peterson IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Buettner H, Robertson DM, Bergstrath EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. The aftermath of Orbital radiotherapy for Grave’s ophthalmopathy Ophthalmology. 2002;109(11):2100–2107.
- Orbital Radiation Therapy for Grave’s Ophthalmopathy Letters to the Editor Ophthalmology. 2003;110 (3):449–454. Ainbinder, DJ, Halligan JB: pg 449 Haddad, H: pg 450 Meyer, D: pg 451 Steinsapir KD, Goldberg RA: pg 452 Bartalena, L: pg 453.
- Cockerham KP, Kennerdell JS. Does Radiotherapy have a role in the management of thyroid orbitopathy? View 1. Br J Ophthalmol. 2002;86:102–104.
- Mourits M Ph. Does radiotherapy have a role in the man- agement of thyroid orbitopathy? View 2 Br J Ophthalmol. 2002;86:104–106.
- McNab AA. Does radiotherapy have a role in the manage- ment of thyroid orbitopathy? Comment. Br J Ophthalmol. 2002;86:106–107.
- Robertson DM, Buettner H, Gorman CA, Garrity JA, Fatourechi V, Bahn, RS, Petersen IA, Stafford SL, Earle JD, 7409180128143000Forbes GS, Kline RW, Bergstralh EJ, Offird KP, Rademacher DM, Stanley NM, Bartley GB. Retinal Microvascular abnormalities in patients treated with exter- nal radiation for Grave’s ophthalmopathy. Arch Ophthal- mol. 2003;121:652–657.
- Soares-Welch CV, Fatourechi V, Bartley GB, Beatty CW, Gorman CA, Bahn RS, Bergstralh EJ, Schleck CD, Garrity JA. Optic Neuropathy of Grave’s disease: results of tansantral orbital decompression and long-term follow-up in 215 patients. Am J Ophthalmol. 2003;136:433–441.
- Schaefer SD, Soliemanzadeh P, Della Rocca DA, Gu-Pei Y, Maher EA, Milite JP, Della Rocca RC. Endoscopic and transconjunctival orbital decomrpession for thyroid-related orbital apex compression. Laryngoscope. 2003;113:508– 513.
- Kacker A, Kazim M, Murphy M, Trokel S, Close L. “Bal- anced” orbital decompression for severe Grave’s orbitopa- thy: technique with treatment algorithm. Otolaryngol Head Neck Surg. 2003;128:228–235.
- White WA, White WL, Shapiro PE. Combined endoscopic median and inferior orbital decompression with Transcutaneous lateral orbital decompression in Grave’s orbitopathy. Ophthalmology. 2003; 110:1827– 1832.